(Q44818645)

English

The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance

scientific article published in April 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

insulin resistance

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Jan J. Štěpán

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Josef V Silha

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Vlasta Justova

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Zdena Lacinova

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Liam J Murphy

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

60

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

442-450

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Increased cerebrovascular mortality in patients with hypopituitarism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Clinical aspects of growth hormone deficiency in adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

New factors in the regulation of adipose differentiation and metabolism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Increased insulin sensitivity in young, growth hormone deficient children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Growth hormone-deficient adults are insulin-resistant.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Effect of growth hormone (GH) on serum concentrations of leptin: study in patients with acromegaly and GH deficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Premature mortality due to cardiovascular disease in hypopituitarism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Growth hormone replacement therapy for adults: into the new millennium.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

The metabolic effects of short-term administration of physiological versus high doses of GH therapy in GH deficient adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2004.02000.X

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44818645&oldid=2047824078"